CTRI/2022/08/044645已完成未知
An open-label, single-arm study to evaluate the efficacy and safety of a Nursing Gel in healthy pregnant female (3rd trimester) and lactating female (post pregnancy mother having 0 month to 3 months old baby) subjects with sore & cracked nipples.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Sex: Females, either of the following
- •a.Healthy pregnant females (3rd trimester).
- •b.Lactating females (post pregnancy mothers having 0 to 3 months old baby).
- •2)Subjects with mild to moderate nipple soreness/pain based on visual analogue scale (VAS).
- •3)For Post Pregnancy Mothers: Subjects having history of delivery within 42 weeks.
- •4)For Pregnant females: Primipara (woman who is giving birth for the first time) subjects, who are diagnosed as pregnant female by gynaecologist.
排除标准
- •1)Subjects having contraindications for breastfeeding
- •2)Newborn with no oral, palatal or maxillofacial abnormalities.
- •3)Subjects with history of development of any breast problem: Mastitis, engorgement etc.
- •4)Subjects not willing to discontinue other nipple crack preventing method during application.
- •5)Subjects who are not taking any pain management medication e.g., NSAIDâ??s, pain killers, etc.
- •6)Participation in a similar clinical study within the previous 90 days.
研究者
相似试验
进行中（未招募）
不适用
Efficacy, safety and pharmacokinetics of artemether-lumefantrine dispersible tablet in the treatment of malaria in infants < 5 kgThe purpose of the study is to obtain efficacy, safety and pharmacokinetic (PK) data following treatment with artemether-lumefantrine dispersible tablet in infants < 5 kg of body weight (BW) with uncomplicated falciparum malaria.MedDRA version: 18.1Level: PTClassification code 10025487Term: MalariaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-005852-33-Outside-EU/EEAovartis Pharma AG30
已完成
不适用
Clinical study to evaluate the safety and efficacy of Stretchmark Oil & Oil Free Hair Oil in healthy pregnant females and lactating females.CTRI/2022/08/044605Zydus Wellness Ltd53
已完成
不适用
Clinical study to evaluate the safety and efficacy of Body Firming Cream and Under Eye Gel in lactating females and only Under Eye Gel in healthy pregnant females.CTRI/2022/08/044565Zydus Wellness Ltd65
进行中（未招募）
1 期
A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients with Early Stage Relapsing Remitting Multiple SclerosisRelapsing remitting multiple sclerosis (RRMS)MedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10048393Term: Multiple sclerosis relapseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: LLTClassification code 10039720Term: Sclerosis multipleSystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-002937-31-SEF. Hoffmann-La Roche Ltd1,225
已完成
3 期
An Open-Label, single-arm study to evaluate the effectiveness and safety of Ocrelizumab in patients with early stage relapsing remitting multiple sclerosismultiple sclerosismsNL-OMON50626Roche Nederland B.V.24